Baker Bros., the largest shareholder, has been aggressively accumulating shares this week with no 10b5-1 plan, signaling strong conviction. Monitor for any upcoming corporate catalysts such as trial data or partnership announcements that may have prompted this buying.
KOD drugs
KOD drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $107.10entry
- T+1 · 7d ago +0.90%α +1.26% · $108.06
- T+5 · 18h ago −5.95%α −4.26% · $100.73
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Baker Bros. Advisors LP, a director and 10% owner, purchased 8,742 shares of Kodiak Sciences at $98.51 for $861,174 on November 4, 2026, outside a 10b5-1 plan. This single insider buy is part of a larger cluster of Baker Bros. purchases totaling over $24.3 million in the past week, representing approximately 0.4% of Kodiak's $6.2B market cap. The buying by a major institutional holder signals conviction in the company's prospects.
Key Financial Metrics
Key Facts
- Baker Bros. Advisors LP, a director and 10% owner, purchased 8,742 shares at $98.51 for $861,174 on November 4, 2026
- Transaction was an open-market purchase (Form 4 code P) with no 10b5-1 plan
- Part of a cluster of Baker Bros. purchases totaling $24.3 million over the past week
- Total cluster value represents approximately 0.4% of Kodiak's $6.2B market cap
- Baker Bros. Advisors is the largest institutional holder with $776M in KOD as of Q2 2026
Financial Impact
Baker Bros. purchased $861K in open-market shares; cluster total $24.3M (0.4% of market cap)
Risk Factors
- Kodiak is a biotech with high volatility (19% normal daily move); stock could move on trial results or regulatory events
- Insider buying does not guarantee near-term positive outcomes; clinical-stage biotech carries binary risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001193125-26-451994 |
Track record
13 reports on KOD
4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +17.99% at T+20 after the Jun 11, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 5/10 Entry $104.93 Now $100.73 +4.00% settles Dec 15
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $109.50 Now $100.73 +8.01% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $111.19 Now $100.73 −9.41% settles Dec 14
- Nov 6, 202610d ago Insider Buy Bullish 5/10 Viewing Entry $107.10 Now $100.73 −5.95% settles Dec 8
- Oct 20, 202627d ago S-3ASR Bearish 5/10 Entry $87.72 Now $100.73 −14.83% settles Nov 18
- Sep 30, 20266w ago SC 13D/A Bullish 7/10 Entry $98.46 to $100.40 Now $100.73 +2.31% ▲ +1.97% +1.27% vs SPY
- Sep 30, 20266w ago Insider Buy Bullish 5/10 Entry $98.46 to $100.40 Now $100.73 +2.31% ▲ +1.97% +1.27% vs SPY
- Sep 28, 20267w ago 8-K Bullish 7/10 Entry $89.92 to $89.60 Now $100.73 +12.02% ▼ −0.36% −0.32% vs SPY
- Aug 13, 202613w ago 8-K Neutral 4/10 No price data
- Aug 13, 202613w ago Press Release Neutral 6/10 Entry $41.35 to $33.14 Now $100.73 +143.60% ▼ −19.85% −17.86% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers